FACTORS INFLUENCING MID-TERM OUTCOMES IN PATIENTS WITH CHRONIC INFRAPOPLITEAL ARTERIAL OCCLUSIVE DISEASE TREATED BY BALLOON ANGIOPLASTY AT THE UNIVERSITY MEDICAL CENTER HO CHI MINH CITY
Main Article Content
Abstract
Objective: To identify factors associated with mid-term outcomes (mortality and limb amputation) in patients with infrapopliteal arterial occlusive disease treated by endovascular intervention at the University Medical Center Ho Chi Minh city.
Methods: This was a prospective cohort observational study including 127 patients with infrapopliteal arterial stenosis or occlusion who underwent balloon angioplasty at the University Medical Center Ho Chi Minh city from January 2022 to July 2024.
Results: During mid-term follow-up, underweight patients had a 3.34-fold higher risk of limb amputation compared with those with normal BMI (95% CI: 1.11-11.0; p = 0.031). Patients who died had significantly lower mean eGFR values than survivors (38.5 ± 23.4 ml/min/1,73m² vs. 69.6 ± 27.4 ml/min/1,73m²; p = 0.022). Other factors, including age, sex, and overweight/obesity, were not significant in the multivariate model.
Conclusion: Poor nutritional status and impaired renal function were independent prognostic factors associated with unfavorable mid-term outcomes after endovascular intervention in patients with infrapopliteal arterial occlusive disease. Nutritional screening and renal function preservation should be emphasized in clinical practice to improve outcomes.
Article Details
Keywords
Infrapopliteal arterial occlusive disease, amputation, mortality, BMI, eGFR.
References
[2] Brice A.E.B, Scierka L.S, Arham A.A, et al. The association of malnutrition with mortality and amputation outcomes in critical limb ischemia: a systematic review. European Heart Journal, 2021,42 (Suppl._1).
[3] Dorros G, Jaff M.R, Murphy K.J, Mathiak L. The
acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Cathet Cardiovasc Diagn,1998, 45 (3): 251-256. https://doi.org/10.1002/(sici)1097-0304(199811)45:3%3C251::aidccd7%3E3.0.co;2-e
[4] Gebauer K, Engelbertz C, Malyar N.M et al. Longterm mortality after invasive angiography and endovascular revascularization in patients with PAD having chronic kidney disease. Angiology, 2016, 67 (6): 556-564. 10.1177/0003319715610335.
[5] Gerhard-Herman M.D, Gornik H.L, Barrett C et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Circulation, 2017, 135 (12): e686-e725. 10.1161/CIR.0000000000000463.
[6] Lim C, Won H, Ko Y.G et al. Association between body mass index and clinical outcomes of peripheral artery disease after endovascular therapy:data from K-VIS ELLA registry. Korean Circ J, 2021,51 (8): 696-707. 10.4070/kcj.2021.0109.
[7] Sidiqi I, Alexander P. Current advances in endovascular therapy for infrapopliteal artery disease. Rev Cardiovasc Med, 2015, 16 (1): 36-50. 10.3909/ ricm06103.
[8] Soder H.K, Manninen H.I, Jaakkola P et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol, 2000, 11(8): 1021-1031. 10.1016/S1051-0443(07)61962-0.
[9] Sugiyama K, Nishibe T, Ogino H. Influence of severe chronic kidney disease on outcomes of endovascular therapy for peripheral artery disease. Journal of Vascular J Medicine & Surgery, 2017, 5(4): 1-6. 10.4172/2329-6925.1000335.